R&D at other companies
Other financials
Where this comes from
Reported directly by TuHURA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about TuHURA Biosciences, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TuHURA Biosciences, Inc.'s R&D?
- TuHURA Biosciences, Inc. (HURA) reported R&D of $5.23M in Q1 2026.
- How has TuHURA Biosciences, Inc.'s R&D changed year-over-year?
- TuHURA Biosciences, Inc.'s R&D increased by 14.2% year-over-year, from $4.58M to $5.23M.
- What is the long-term trend for TuHURA Biosciences, Inc.'s R&D?
- Over 2 years (2023 to 2025), TuHURA Biosciences, Inc.'s R&D has grown at a 47.8% compound annual growth rate (CAGR), from $9.4M to $20.53M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.